5-Methyl-5, 6-dihydrouridine 24-acid 3-dihydro-1H-indol-3-ylidene)methyl]-N-[2-hydroxy-3-(morpholin-4-yl)propyl]-2

3-dihydro-1H-indol-3-ylidene)methyl]-N-[2-hydroxy-3-(morpholin-4-yl)propyl]-2

FDA Approves Qinlock (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor

The oral Berbamine treatment greatly suppresses the growth of Huh7 xenografted tumors over the time and leads to a tumor reduction by 70% based on the tumor weight

3R)-2-amino-3-hydroxybutanamido)-3-(4-hydroxyphenyl)propanamido)propanamido)-6-benzyl-9-sec-butyl-42-carbamoyl-21

Smiles: OC(=O)[C@]1(C[C@@H](O)[C@H](O)[C@@H](C1)OC(=O)C=CC1=CC(O)=C(O)C=C1)OC(=O)C=CC1=CC(O)=C(O)C=C1

5-Methyl-5, 6-dihydrouridine 24-acid 3-dihydro-1H-indol-3-ylidene)methyl]-N-[2-hydroxy-3-(morpholin-4-yl)propyl]-25 Methyl 5,6 dihydrouridine is a minor constituent in the chromosomal RNA of the rat ascites tumor. 5 Methyl 5,6 dihydrouridine can be used for nucleic acid modification. Product information CAS Number: 23067 10 9 Molecular Weight: 260. 24 Formula: C10H16N2O6 Chemical Name: 1 [(2R,3R,4S,5R) 3,4 dihydroxy 5 (hydroxymethyl)oxolan 2 yl] 5 methyl 1,3 diazinane 2,4 dione Smiles: CC1CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)NC1=O InChiKey: BTFXIEGOSDSOGN